Nancy is a registered patent attorney and intellectual property litigator. She works with the IP litigation team in representing leading companies in a wide range of patent infringement matters. 

Nancy also has experience advising clients on prosecution strategies for life science technologies, including antibody technologies, pharmaceuticals, biologics, CRISPR/Cas technologies, therapeutic and active agent delivery systems, and medical devices, among others. Her experience further encompasses counseling clients on patent licensing and procurement.

Before joining DLA Piper LLP, Nancy worked extensively as an IP journalist at the largest online intellectual property publication in the world, IPWatchdog, Inc.